Parent Project Muscular Dystrophy (PPMD)

[Available On-Demand]
PPMD created and submitted the “Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment over the Spectrum of Disease” which acted as a pillar in the creation and publication of the FDA Duchenne Guidance, the first guidance drafted by the patient community.
Speakers
photo
Chief Advocacy Officer
Parent Project Muscular Dystrophy
photo
Senior Administrative Manager
Michigan Medicine Experience Analytics and Insights